NSEStatement of deviation(s) or variation(s) under Reg. 326 Aug 2026 · 6 Aug 2026, 08:26 pm
Statement of deviation(s) or variation(s) under Reg. 32
Healthcare Global Enterprises Limited · HCG
✦ AI SummaryResults
Healthcare Global Enterprises Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 for the quarter ended June 30, 2026, regarding the utilisation of funds raised through Rights Issue.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Healthcare Global Enterprises Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
Attachments (1)
📄pdf
Download →
HCG1_06082026202613_SE_Intimation_Reg_32_30_June_2026.pdf
View document text
August 06, 2026
National Stock Exchange of India Limited, BSE Limited,
Compliance Department, Compliance Department,
Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers,
Bandra (East), Mumbai - 400051, Dalal Street, Mumbai - 400001,
Maharashtra, India Maharashtra, India
Dear Sir/Madam,
Subject : Statement of deviation or variation for funds raised through Rights Issue for the
quarter ended June 30, 2026
Stock Code : BSE – 539787, NSE – HCG
Reference : Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 read with SEBI circular no. CIR/CFD/CMD1/162/2019
dated December 24, 2019 (“Listing Regulations”).
Pursuant to the Listing Regulations, we hereby confirm that there was no deviation or variation in the
utilisation of the proceeds raised through the Rights Issue of the Company during the quarter ended
June 30, 2026, from the objects stated in the Letter of Offer dated February 24, 2026.
In this regard, please find enclosed herewith, as Annexure, the statement confirming that there was no
deviation or variation in the utilisation of the aforesaid proceeds for the quarter ended June 30, 2026,
from the objects stated in the Letter of Offer, in accordance with SEBI Circular No.
CIR/CFD/CMD1/162/2019 dated December 24, 2019. The said statement has been duly reviewed by
the Audit Committee of the Company.
The above information is also available on the website of the Company and can be accessed at:
https://www.hcgoncology.com/
You are requested to take the information on record.
Thanking You,
For HealthCare Global Enterprises Limited
Sunu Manuel
Company Secretary and Compliance Officer
Encl: As above
HealthCare Global Enterprises Limited
Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India
Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India
91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489
Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag
ANNEXURE
The additional disclosures as required under the Listing Regulations and SEBI Circular no.
CIR/CFD/CMD1/162/2019 dated December 24, 2019, as amended from time to time, with respect to
statement of deviation or variation in the utilisation of funds raised through Rights Issue for the quarter
ended June 30, 2026.
Name of Listed Entity HealthCare Global Enterprises Limited
Mode of Fund Raising Public Issues / Rights Issues / Preferential Issues /
QIP / Others
Date of Raising Funds March 27, 2026
Amount Raised Rs. 424,68,17,792 (Indian Rupees Four Hundred
Twenty-Four Crore Sixty-Eight Lakh Seventeen
Thousand Seven Hundred and Ninety-Two Only)
Report filed for the quarter ended June 30, 2026
Monitoring Agency Applicable / Not applicable
Monitoring Agency Name, if applicable CARE Ratings Limited
Is there a Deviation / Variation in use of funds Yes / No
raised.
If yes, whether the same is pursuant to change in Not Applicable
terms of a contract or objects, which was approved
by the shareholders.
If Yes, Date of shareholder Approval Not Applicable
Explanation for the Deviation / Variation Not Applicable
Comments of the Audit Committee after review No comments
Comments of the auditors, if any No comments
HealthCare Global Enterprises Limited
Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India
Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India
91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489
Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag
Objects for which funds have been raised and where there has been a deviation, in the following table
Original Object Modified Original Modified Funds Amount of Remarks
Object, if Allocation allocation, Utilised Deviation/Variation if any
any (Rs in if any for the quarter
Crores) according to
applicable object
Pre-payment and/or N.A. 170.00 Nil 170.00 Nil
repayment of all, or a
portion of, certain
outstanding borrowings
availed by Company and
wholly owned Subsidiary
HCG NCHRI Oncology
Part-payment of N.A. 154.04 Nil 154.04 Nil
consideration for
acquisition of 34.00%
additional stake in equity
share capital of Vizag
Hospital and Cancer
Research Center Private
Limited, one of existing
Subsidiaries.
General Corporate N.A. 95.57 Nil 95.83* Nil As
Purposes detailed
in the
Issue related expenses N.A. 5.07 Nil 4.81* Nil Note
below
TOTAL 424.68 424.68
Deviation or variation could mean:
(a) Deviation in the objects or purposes for which the funds have been raised or
(b) Deviation in the amount of funds actually utilized as against what was originally disclosed or
(c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc.
*Note: The actual Issue Related Expenses incurred were Rs. 4.81 crore as against the estimated
allocation of Rs. 5.07 crore. Consequently, the unutilized amount of Rs. 0.26 crore was utilized towards
General Corporate Purposes, resulting in utilization of Rs. 95.83 crore (which is less than 25% of the
total issue size) under General Corporate Purposes as compared to the originally allocated amount of
Rs. 95.57 crore. There was no change in the overall utilization of the net proceeds from the Issue. Please
note that the aforesaid utilization is in accordance with the disclosures set out in the Offer Document
and is within the overall limit prescribed under the SEBI (Issue of Capital and Disclosure Requirements)
Regulations, 2018.
HealthCare Global Enterprises Limited
Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India
Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India
91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489
Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag